Short answer
Amgen (AMGN) filed an 8-K current report with the SEC on May 19, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CFO Peter Griffith retires August 31, 2026, remaining an executive vice president through January 31, 2027.
Amgen 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CFO Peter Griffith retires August 31, 2026, remaining an executive vice president through January 31, 2027
- Thomas Dittrich becomes CFO September 1, 2026, following a two-month transition period
- Dittrich brings prior Amgen finance experience and recent CFO leadership at Galderma, including its 2024 IPO
- 2026 compensation includes CHF 4.5M long-term incentives, CHF 4.7M replacement RSUs, and CHF 4.0M cash bonus
- Additional CHF 5.8M two-year retention bonus and severance protection increase transition-related compensation obligations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Amgen 8-K filings
Get the next AMGN 8-K as it lands
Follow AMGN for push alerts, or ask the research agent what this filing means.